| http://www.w3.org/ns/prov#value | - As evidence of the success of BioPlus??? efforts, the latest compliance statistics from a sampling of the treatment programs at BioPlus, which includes more than 22,200 BioPlus patients being treated for hepatitis, oncology, rheumatoid arthritis, psoriasis, Crohn???s disease, and other conditions, finds that BioPlus achieves a 91 percent compliance rate at discharge.
|
